Devika P T, Stanely Mainzen Prince P
Department of Biochemistry and Biotechnology, Annamalai University, Annamalainagar-608 002, Tamil Nadu, India.
Biomed Pharmacother. 2008 Dec;62(10):701-8. doi: 10.1016/j.biopha.2007.10.011. Epub 2007 Nov 20.
This study aims to evaluate the preventive effect of (-)-epigallocatechin-gallate (EGCG) on lipid peroxides, enzymatic and non-enzymatic antioxidants and histopathological findings in isoproterenol (ISO)-induced rats. Myocardial infarction (MI) is induced in rats by subcutaneous injection of ISO (100 mg/kg body weight) at an interval of 24h for 2 days. ISO-treated rats show a significant increase in the levels of thiobarbituric acid reactive substances, lipid hydroperoxides in plasma and heart and plasma uric acid and a significant decrease in the activities of superoxide dismutase, catalase, glutathione peroxidase, glutathione reductase and glutathione-S-transferase in heart and the levels of reduced glutathione, vitamin C and vitamin E in plasma and the heart and ceruloplasmin in plasma. Oral pretreatment with EGCG (10, 20 and 30 mg/kg body weight) daily for a period of 21 days show significant decrease in the levels of lipid peroxidation products and uric acid and improved the antioxidant status by increasing the activities of antioxidant enzymes and non-enzymic antioxidants. Histopathological findings of the myocardial tissue show the protective effect of EGCG in ISO-induced rats. The effect at a dose of 30 mg/kg of EGCG was more pronounced than that of the other two doses (10 and 20 mg/kg body weight). Thus, the present study reveals that EGCG exerts cardioprotective effect against ISO-induced MI due to its free radical scavenging and antioxidant effects, which maintains the tissue defense system against myocardial damage.
本研究旨在评估(-)-表没食子儿茶素-3-没食子酸酯(EGCG)对异丙肾上腺素(ISO)诱导的大鼠脂质过氧化物、酶促和非酶促抗氧化剂以及组织病理学结果的预防作用。通过皮下注射ISO(100mg/kg体重),间隔24小时,连续2天诱导大鼠心肌梗死(MI)。ISO处理的大鼠血浆和心脏中的硫代巴比妥酸反应性物质、脂质氢过氧化物水平以及血浆尿酸显著升高,而心脏中超氧化物歧化酶、过氧化氢酶、谷胱甘肽过氧化物酶、谷胱甘肽还原酶和谷胱甘肽-S-转移酶的活性以及血浆和心脏中还原型谷胱甘肽、维生素C和维生素E以及血浆铜蓝蛋白的水平显著降低。每天口服EGCG(10、20和30mg/kg体重)进行21天预处理,结果显示脂质过氧化产物和尿酸水平显著降低,并通过增加抗氧化酶和非酶促抗氧化剂的活性改善了抗氧化状态。心肌组织的组织病理学结果显示EGCG对ISO诱导的大鼠具有保护作用。30mg/kg剂量的EGCG的效果比其他两个剂量(10和20mg/kg体重)更明显。因此,本研究表明,EGCG因其自由基清除和抗氧化作用而对ISO诱导的MI发挥心脏保护作用,从而维持组织防御系统免受心肌损伤。